Back
Starbucks Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
33
SBUX
Starbucks
Last Price:
75.71
Seasonality Move:
4.67%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
41.11
Seasonality Move:
12.29%
Sell
33
Starbucks (SBUX)
is a Sell
Is Starbucks a Buy, Sell or Hold?
- The current Starbucks [SBUX] share price is $75.70. The Score for SBUX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- SBUX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $41.12. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SBUX Stock Price Chart
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $41.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
SBUX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.53 | Sell |
Relative Strength Index (14 RSI): | 31.86 | Sell |
Chaikin Money Flow: | 615552 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (75.27 - 87.99) | Sell |
Bollinger Bands (100): | (83.84 - 96) | Sell |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.38 | Sell |
Relative Strength Index (14 RSI): | 36.17 | Sell |
Chaikin Money Flow: | -526969 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.16 - 45.34) | Sell |
Bollinger Bands (100): | (43.31 - 49.39) | Sell |
SBUX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 74.78 | Buy |
20-day SMA: | 80.66 | Sell |
50-day SMA: | 85.96 | Sell |
200-day SMA: | 93.61 | Sell |
8-day EMA: | 76.05 | Sell |
20-day EMA: | 79.26 | Sell |
50-day EMA: | 84.39 | Sell |
200-day EMA: | 92.14 | Sell |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.46 | Sell |
20-day SMA: | 42.72 | Sell |
50-day SMA: | 45.61 | Sell |
200-day SMA: | 42.06 | Sell |
8-day EMA: | 41.51 | Sell |
20-day EMA: | 42.79 | Sell |
50-day EMA: | 44.59 | Sell |
200-day EMA: | 44.26 | Sell |
Starbucks Earnings Growth & SBUX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.11 per share, an increase this year of $0.17 per share, and an increase next year of $0.53 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.
Starbucks Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |